Certificate of Analysis (COA)
View the laboratory certificate for this product
[ View COA ]
Pure Prostamax 20mg | KEDP Research Peptide
R 918.85
Pure Prostamax 20mg
Pure Prostamax 20mgis a research-grade peptide supplied byPure Performance Labsin a lyophilized powder format for laboratory and scientific research applications.
Prostamax is associated with the short peptide sequenceLys-Glu-Asp-Pro (KEDP)and is studied within the broader field of peptide bioregulator research. Pure Performance Labs currently identifies the product as a20mg research-grade peptideand lists the KEDP sequence in its product specifications.
About Prostamax
Prostamax is a synthetic tetrapeptide identified asLys-Glu-Asp-Pro (KEDP). Research literature has examined KEDP in the context of peptide bioregulators, cellular and chromatin-related investigations, and experimental prostate-tissue models.
The currently available research base should be understood aspreclinical and laboratory research, rather than evidence of established human efficacy. Available reviews identify in-vitro and animal research rather than controlled human clinical trials.
What is Pure Prostamax 20mg? Pure Prostamax 20mg is a research-grade peptide supplied as a lyophilized research material.
What is the sequence of Prostamax? Prostamax is identified as Lys-Glu-Asp-Pro (KEDP).
What is Prostamax researched for? KEDP has been investigated in peptide bioregulator, cellular, chromatin and experimental tissue research.
What is the strength? The product is supplied at 20mg.
Is Prostamax clinically established? Available research is predominantly preclinical and laboratory-based rather than controlled human clinical research.
Is a COA available? Batch-specific Certificate of Analysis documentation should be consulted where available.
What form is the product supplied in? Pure Prostamax is supplied as a lyophilized research peptide.
Is this product intended for human use? No. It is supplied for laboratory and scientific research purposes only.
Prostamax is a synthetic tetrapeptide identified as Lys-Glu-Asp-Pro (KEDP). Research has examined this peptide within the broader field of peptide bioregulator research, including cellular, chromatin and experimental tissue models. Current evidence is predominantly preclinical and laboratory-based.